The Group Solabia announces the acquisition of Mibelle Biochemistry, reinforcing its position in the cosmetic and nutraceutical ingredients sector.
Solabia, a recognized player in the field of biotech-derived active ingredients, has signed an agreement to acquire the Swiss company Mibelle Biochemistry. This strategic acquisition aims to create a leading independent player in the cosmetic and nutraceutical ingredients sector. Mibelle Biochemistry, which specializes in the development and production of high-performance active ingredients, is currently owned by the Persán multinational group.
Background and objectives of the acquisition
Founded in 1991, Mibelle Biochemistry offers a wide range of products dedicated to skin beauty, healthy aging, hair care and cognitive support, available in over 50 countries. Jean-Baptiste Dellon, President and CEO of Solabia, commented: « We are delighted to welcome Mibelle Biochemistry's expert teams to Solabia. It's a company we've long admired for its scientific rigor, innovative spirit and forward-thinking work. "
This merger will bring together two organizations committed to scientific research and innovation. By combining expertise in advanced biotechnology, plant science and sustainable innovation, Solabia aims to broaden its portfolio, while maintaining Mibelle Biochemistry's reputation for Swiss quality.
Future prospects for both companies
Cornelia Schürch, Managing Director of Mibelle Biochemistry, emphasized: « For over three decades, Mibelle Biochemistry has built a worldwide reputation for cutting-edge biotechnology and high-quality natural active ingredients. Joining Solabia marks an exciting new step for our team. »This partnership is intended to offer solutions tailored to the growing needs of the cosmetics and nutraceuticals market.
The transaction is expected to be finalized in the coming months.
